Study of Erlotinib and Metformin in Triple Negative Breast Cancer
Clinical trial NCT01650506 · COMPLETED
Trial details
- NCT number
- NCT01650506
- Sponsor
- Columbia University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2016-06-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.